Pulmonary aspergillosis represents a common, potentially lethal opport
unistic infection that has four unique forms: allergic bronchopulmonar
y aspergillosis (ABPA), aspergilloma, and invasive and semi-invasive a
spergillosis. In individuals who are at risk, pulmonary aspergillosis
is characterized by a spectrum of clinical and radiographic findings t
hat are intrinsically related to the status of the immune system or th
e presence of structural lung disease. ABPA, occurring almost exclusiv
ely in asthma patients, is characterized radiographically by fleeting
pulmonary alveolar opacities caused by deposition of immune complexes
and inflammatory cells within the lung parenchyma. Mucus plugging and
bronchial wall thickening can be expected in time. Aspergilloma, occur
ring in patients with structural lung disease, typically appears radio
graphically as a focal intracavitary mass and is characterized initial
ly by an increase in the wall thickness of a preexisting cavity or cys
t. Invasive aspergillosis, which occurs primarily in profoundly immuno
compromised patients, may exhibit nonspecific patchy nodular opacities
or lobar-type air-space disease in cases with vascular invasion. Comp
uted tomography may reveal a halo or ground-glass attenuation and is m
ore accurate in the detection of early disease. Cavitation often devel
ops with time and typically results in the air crescent sign. Semi-inv
asive aspergillosis is radiographically similar to the invasive form b
ut differs in clinical course, being associated with mild immunosuppre
ssion or chronic illness and typically progressing over the course of
months rather than weeks.